Ascendis Pharma A/S (asnd 2.25 04/01/28)
13F holders, Q1 2024 (March 31)3holders
$4.08avg. 13F price*
At the end of Q1 2024, 3 institutions reported holding Ascendis Pharma A/S (asnd 2.25 04/01/28) in their 13F filings. The largest holders were Boussard & Gavaudan Investment Management LLP ($6.9M), BNP PARIBAS ASSET MANAGEMENT Holding S.A. ($2.3M) and Jane Street Group, LLC ($402K).
- Company
- Ascendis Pharma A/S (asnd 2.25 04/01/28)
- CUSIP
- 04351PAD3
- Latest filing quarter
- Q1 2026
History
Number of 13F holders
Total Exit/New Position Q1 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 2 | $9.2M |
| Exits | 2 | $2.1M |
Ownership 3 holders
| Boussard & Gavaudan Investment Management LLP | 1.26% | New | 6,000 | $6.9M |
| BNP PARIBAS ASSET MANAGEMENT Holding S.A. | 0.01% | New | 2,000,000 | $2.3M |
| Jane Street Group, LLC | 0.00% | Reduce -96.5% | 350,000 | $402K |
"% of holder's portfolio" is ASCENDIS PHARMA A/S (ASND 2.25 04/01/28)'s weight in each manager's 13F, not the share of Ascendis Pharma A/S (asnd 2.25 04/01/28) the manager owns.